MP
MPCI.EGX Memphis Pharmaceuticals
326.00 EGP
Close of Oct 29, 2026
130.14
446.00
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is MPCI.EGX undervalued?
Graham numberThe Graham number of Memphis Pharmaceuticals cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Memphis Pharmaceuticals fundamental analysis
No fundamental analysis for Memphis Pharmaceuticals yet.
Memphis Pharmaceuticals stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Financial statements of Memphis Pharmaceuticals are not available yet.
Memphis Pharmaceuticals dividends
Memphis Pharmaceuticals has not paid dividends in the last 1 fiscal years.
Who owns Memphis Pharmaceuticals
Ownership data of Memphis Pharmaceuticals is not available yet.
Memphis Pharmaceuticals company profile
- Company name
- Memphis Pharmaceuticals
- Ticker
- MPCI.EGX
- ISIN
- EGS38351C010
- Exchange
- Egyptian Exchange
- Sector
- -
- Industry
- -
- Address
- Website
- -